What is Antiviral Drugs Treatment Market?
Antiviral drugs are a type of medicine that has been used to treat viral infections such as measles, HIV, influenza, and hepatitis. Vaccines are widely used to prescribe such medicines. Furthermore, the majority of these medications are used to treat common viral infections, while only a few (full-spectrum antiviral drugs) are effective against a wide range of viruses. Antiviral drug demand is expected to increase as the incidence of viral infections such as HIV, hepatitis, respiratory syncytial virus (RSV), and influenza increases. Furthermore, the new COVID-19 situation has enhanced influenza virus surveillance among the general public. Along with checking for COVID-19 in the test sample offered by the symptomatic patient, numerous countries are now testing for influenza virus, which has improved the disease's diagnosis. WHO also encourages countries to maintain routine influenza surveillance and, where resources allow, test samples from influenza surveillance sites for influenza and SARS-CoV-2 viruses.
The market study is being classified by Type (Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors and Immune System Modulators), by Application (Hepatitis, HIV/AIDS, Herpes and Influenza) and major geographies with country level break-up.
AbbVie Inc. (United States), AstraZeneca(United Kingdom), Boehringer Ingelheim (Germany), Bristol-Meyrs Squibb Company (United States), Cipla Inc. (India), Gilead Sciences Inc. (United States), GlaxoSmithKline PLC (United Kingdom), Johnson & Johnson (United States), Novartis AG (Switzerland), Pfizer Inc. (United States) and Sanofi (France) are some of the key players profiled in the study.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Antiviral Drugs Treatment market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Antiviral Drugs Treatment market by Type, Application and Region.
On the basis of geography, the market of Antiviral Drugs Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Initiatives to Curb Viral Diseases by Public and Private Companies
- Advancements in Epidemiology and Growing Awareness of Viral Diseases
- Advancements in Molecular Biology Promoting Drug Development
- High Cost of Antiviral Drug Treatment
- Rising Government Investment on Research and Development
In October 2020, Gilead Sciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for its antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization.
Key Target AudienceAntiviral Drug Treatment Providers, Healthcare Industry, Pharmaceutical Industry, Regulatory Bodies and Governmental Bodies
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase